NO20052251L - Nasalt anvendbart farmasoytisk preparat og fremstilling derav. - Google Patents

Nasalt anvendbart farmasoytisk preparat og fremstilling derav.

Info

Publication number: NO20052251L
Authority: NO; Norway
Prior art keywords: composition; buffer; pharmaceutical composition; osmotic; preparation
Prior art date: 2002-10-10

Application number

NO20052251A

Other languages

English (en)

Norwegian (no)

Inventor

Gerhard Hantich

Ernst Hesse

Helmut Scheidl

Wolfgang H Nitschmann

Original Assignee

Gebro Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-10

Filing date

2005-05-09

Publication date

2005-05-09

2005-05-09 Application filed by Gebro Pharma Gmbh filed Critical Gebro Pharma Gmbh

2005-05-09 Publication of NO20052251L publication Critical patent/NO20052251L/no

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
239000000872 buffer Substances 0.000 abstract 4
239000000203 mixture Substances 0.000 abstract 3
239000003755 preservative agent Substances 0.000 abstract 3
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
235000011090 malic acid Nutrition 0.000 abstract 2
230000003204 osmotic effect Effects 0.000 abstract 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 2
230000002335 preservative effect Effects 0.000 abstract 2
239000000080 wetting agent Substances 0.000 abstract 2
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 abstract 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
229910019142 PO4 Inorganic materials 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
229960000686 benzalkonium chloride Drugs 0.000 abstract 1
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 abstract 1
239000000839 emulsion Substances 0.000 abstract 1
239000001630 malic acid Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000010452 phosphate Substances 0.000 abstract 1
239000000377 silicon dioxide Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Immunology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20052251A 2002-10-10 2005-05-09 Nasalt anvendbart farmasoytisk preparat og fremstilling derav. NO20052251L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AT0154002A AT413078B (de)	2002-10-10	2002-10-10	Verwendung eines puffers auf basis von apfelsäure für die herstellung einer nasal applizierbaren zubereitung
PCT/AT2003/000306 WO2004032896A1 (de)	2002-10-10	2003-10-09	Nasal applizierbare pharmazeutische zubereitung und deren herstellung

Publications (1)

Publication Number	Publication Date
NO20052251L true NO20052251L (no)	2005-05-09

Family

ID=32074994

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20052251A NO20052251L (no)	2002-10-10	2005-05-09	Nasalt anvendbart farmasoytisk preparat og fremstilling derav.

Country Status (9)

Country	Link
US (1)	US20060127317A1 (de)
EP (1)	EP1549288A1 (de)
JP (1)	JP2006503868A (de)
AT (1)	AT413078B (de)
AU (1)	AU2003266811A1 (de)
CA (1)	CA2501760A1 (de)
NO (1)	NO20052251L (de)
PL (1)	PL375762A1 (de)
WO (1)	WO2004032896A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102007006122A1 (de) *	2007-02-02	2008-08-07	Krewel Meuselbach Gmbh	Cistusextrakte
US20130213393A1 (en)	2009-12-22	2013-08-22	Evoke Pharma, Inc.	Nasal formulations of metoclopramide
ES2750246T3 (es) *	2013-10-08	2020-03-25	Innopharma Inc	Formulaciones liquidas orales de aprepitant
EP3554489A4 (de)	2016-12-15	2020-06-17	Evoke Pharma, Inc.	Behandlung von mässiger bis schwerer gastroparese

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5514670A (en) *	1993-08-13	1996-05-07	Pharmos Corporation	Submicron emulsions for delivery of peptides
AT409081B (de) *	2000-02-16	2002-05-27	Gebro Pharma Gmbh	Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung

2002
- 2002-10-10 AT AT0154002A patent/AT413078B/de active
2003
- 2003-10-09 CA CA002501760A patent/CA2501760A1/en not_active Abandoned
- 2003-10-09 AU AU2003266811A patent/AU2003266811A1/en not_active Abandoned
- 2003-10-09 WO PCT/AT2003/000306 patent/WO2004032896A1/de not_active Ceased
- 2003-10-09 PL PL03375762A patent/PL375762A1/xx not_active Application Discontinuation
- 2003-10-09 EP EP03747695A patent/EP1549288A1/de not_active Withdrawn
- 2003-10-09 JP JP2004542079A patent/JP2006503868A/ja not_active Withdrawn
- 2003-10-09 US US10/530,969 patent/US20060127317A1/en not_active Abandoned
2005
- 2005-05-09 NO NO20052251A patent/NO20052251L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2004032896A1 (de)	2004-04-22
AU2003266811A1 (en)	2004-05-04
PL375762A1 (en)	2005-12-12
US20060127317A1 (en)	2006-06-15
ATA15402002A (de)	2005-04-15
CA2501760A1 (en)	2004-04-22
EP1549288A1 (de)	2005-07-06
JP2006503868A (ja)	2006-02-02
AT413078B (de)	2005-11-15

Similar Documents

Publication	Publication Date	Title
BRPI0311877B8 (pt)	2021-05-25	formulação farmacêutica ácida de insulina com estabilidade aperfeiçoada
ES2150940T3 (es)	2000-12-16	Formulacion proteinica que comprende hormona del crecimiento.
ATE535943T1 (de)	2011-12-15	Dotierpasten zur erzeugung von p, p+ und n, n+ bereichen in halbleitern
WO2004032979A3 (en)	2004-07-01	Acidified chlorite compositions containing nitrogenous stabilizers and systems and methods related thereto
NO20012661L (no)	2001-05-30	Fremgangsmåte for å redusere astringens av tinn(II) i dentifriciumsammensetninger
CA2397496A1 (en)	2001-09-07	Acidic antimicrobial compositions for treating food and food contact surfaces and methods of use thereof
DE60318867D1 (de)	2008-03-13	Lösung zur nagel-verwendung
BR0112461A (pt)	2003-07-22	Composições que contém componentes terapeuticamente ativos tendo uma solubilidade aumentada
IS8870A (is)	2010-01-06	Lyfjablanda sem felur í sér andrógen
WO2005116081A3 (en)	2006-07-06	Stable protein storage and stable nucleic acid storage in recoverable form
CA2027483A1 (fr)	1991-04-14	Procede de preparation d'une solution aqueuse effervescente ayant une action emolliente sur la cuticule des ongles, composition pour la mise en oeuvre dudit procede et traitement cosmetique correspondant
EP1236398A4 (de)	2004-04-07	Mikrobizide zusammensetzungen
WO2000066180A3 (en)	2001-11-29	Method for enhancing contrast produced by mri
CA2116066A1 (en)	1994-08-24	Stabilized composition of troponin for immunoassays and process for stabilizing troponin for immunoassays
EP1153901A3 (de)	2004-01-02	Zusammensetzung zur Erhöhung der Nahrungsqualität von Gemüse und deren Verwendung
CA2256410A1 (en)	1997-12-04	Stable pharmaceutical composition of bdnf
PL357132A1 (en)	2004-07-12	Stable, nasally, orally or sublingually applicable pharmaceutical preparation
CA2388056A1 (en)	2001-05-25	Method of stabilizing dye solutions and stabilized dye compositions
WO2006039231A3 (en)	2006-07-20	Topical formulations for the treatment of depression with s adenosyl methionine
WO2005115416A3 (en)	2006-11-16	Method of treating with chlorine dioxide
NO20052251L (no)	2005-05-09	Nasalt anvendbart farmasoytisk preparat og fremstilling derav.
EP0985347A4 (de)	2002-10-09	Brausezubereitung für pflanzen
KR930000096A (ko)	1993-01-15	제제
CA2438622A1 (en)	2002-09-12	Compositions containing creatine and creatinine
EP1552838A4 (de)	2007-12-12	Rubrofusarin-glycosid-haltige zusammensetzung

Legal Events

Date	Code	Title	Description
2009-05-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application